Mount Sinai Heath System

New York, New York 10019-1147

0 studies enrolling now · 1 studies all time

What they study most

Clear Cell Renal Cell Carcinoma, Kidney Cancer, RCC, Renal Cell Carcinoma, ccRCC

Studies at this site

• A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) — Running, not enrolling